Eckert & Ziegler AG

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
#1
From Google Finance : Eckert & Ziegler Strahlen und Medizintechnik AG is a Germany-based Company engaged in the development and production of isotope technology components and medical technology equipment for medicine, science and manufacturing sectors. The Company operates in four main segments: Isotope Products, Radiation Therapy, Radiopharma, and Environmental Services. The Company manufactures products for diagnosis and treatment of cancer, remediation of contaminated sites and thickness measurement devices do the paper industry, among others. The Company has seven production sites and 10 distribution sites located worldwide and operates approximately 25 subsidiaries.

From Yahoo Finance : Key statistics are that it is a 131 Million Market Cap Company.

Most importantly, its EV/EBITDA is 5.1, screaming value buy at that EV/EBITDA.

Share price has fallen by 18% in last one month due to a result announcement that profit will fall by 15%.

The dividend is 0.6 Euro, with a 2.4% yield on cost.

I have done up a blog post on this, available here http://sgx-stocks-sti.blogspot.sg/2014/0...er-ag.html

Broadly, if you want to look at a stock for a 30% appreciation potential, this could be your ticket, if you buy at around 21 Euro.
Disclaimer :-

I am not an investment professional.

I encourage you to do your own independent "due diligence" on any idea that I write about, because I could be and probably am wrong.

Nothing written here is an invitation to buy or sell any particular stock.

At most, I am handing out an educated guess as to what the markets may do.

The market will always find a new way to make a fool out of me (and maybe, even you!).

Even the best strategies of the past fail, sometimes spectacularly, when you least expect it.

I am not immune to that, so please understand that any past success of mine will probably be followed by failures
Reply
#2
had written about Eckert & Ziegler last month.

http://sgx-stocks-sti.blogspot.sg/2014/0...er-ag.html

This post is to look at a recent development which may have an impact on Eckert & Ziegler.

http://sgx-stocks-sti.blogspot.sg/2014/0...nc_30.html

Nordion is a similar company in Canada, which has recently i.e. yesterday been acquired.

Eckert & Ziegler has an Enterprise Value / EBITDA multiple of 4.87.

Data provided by Capital IQ, except where noted.
Valuation Measures
Market Cap (intraday)5: 128.29M
Enterprise Value (Mar 31, 2014)3: 118.25M
Trailing P/E (ttm, intraday): 13.59
Forward P/E (fye Dec 31, 2014)1: N/A
PEG Ratio (5 yr expected)1: N/A
Price/Sales (ttm): 1.08
Price/Book (mrq): 1.59
Enterprise Value/Revenue (ttm)3: 1.00
Enterprise Value/EBITDA (ttm)6: 4.87

Nordion which has been acquired was having a multiple of 6.05.

Valuation Measures
Market Cap (intraday)5: 644.47M
Enterprise Value (Mar 31, 2014)3: 363.63M
Trailing P/E (ttm, intraday): 2.36
Forward P/E (fye Oct 31, 2015)1: 12.39
PEG Ratio (5 yr expected)1: -0.28
Price/Sales (ttm): 2.60
Price/Book (mrq): 1.40
Enterprise Value/Revenue (ttm)3: 1.46
Enterprise Value/EBITDA (ttm)6: 6.05

This means that an acquisition price of 11.75, Nordion has a EV/EBITDA multiple of 6.82.

Applying that multiple to Eckert & Ziegler, provides one with a target price of 34.01, against its current price of 24.26.

The upside is around 40%.

I am not currently long the stock as I wanted to wait till it hits 20.87 before buying it.

However, with Nordion's acquisition, chances are somebody will make the connection like me and bid it up.

Hence, I am planning to go long within the next couple of days.

http://sgx-stocks-sti.blogspot.sg/2014/0...er-ag.html
Reply


Forum Jump:


Users browsing this thread: 2 Guest(s)